Long-term follow-up on overall survival and independent review of response in CheckMate 214: First-line nivolumab plus ipilimumab (N+I) versus sunitinib (S) in patients (pts) with advanced renal cell carcinoma (aRCC) Meeting Abstract
| Authors: | Grimm, M. O.; Tannir, N.; McDermott, D.; Escudier, B.; Hammers, H.; Frontera, O. A.; Plimack, E.; Barthelemy, P.; Neiman, V.; George, S.; Porta, C.; Powles, T.; Donskov, F.; Amin, A.; Tykodi, S.; Tomita, Y.; Rini, B.; McHenry, M. B.; Saggi, S. S.; Motzer, R. |
| Abstract Title: | Long-term follow-up on overall survival and independent review of response in CheckMate 214: First-line nivolumab plus ipilimumab (N+I) versus sunitinib (S) in patients (pts) with advanced renal cell carcinoma (aRCC) |
| Meeting Title: | 2020 Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (DGHO) |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 43 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Oct 9-11 |
| Meeting Location: | Virtual |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2020-10-01 |
| Start Page: | 208 |
| Language: | English |
| ACCESSION: | WOS:000575955000470 |
| PROVIDER: | wos |
| DOI: | 10.1159/000510995 |
| Notes: | Meeting Abstract: 66 -- "2020 Virtual Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology" -- Source: Wos |
